Differential expression and prognostic value of HMGA1 in pancreatic head and periampullary cancer

European Journal of Cancer

Volumn 46, Issue 18, 2010, Pages 3393-3399

  Van Der Zee, Jill A ^a   Ten Hagen, Timo L M ^a   Hop, Wim C J ^a   Van Dekken, Herman ^a   Dicheva, Bilyana M ^a   Seynhaeve, Ann L B ^a   Koning, Gerben A ^a   Eggermont, Alexander M M ^a   Van Eijck, Casper H J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

HMGA1; Immunohistochemistry; Pancreatic cancer; Pancreatic head cancer; Periampullary cancer; Prognosis

Indexed keywords

CISPLATIN; FLUOROURACIL; FOLINIC ACID; HIGH MOBILITY GROUP A PROTEIN; HIGH MOBILITY GROUP A1 PROTEIN; MITOXANTRONE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CONTINUOUS INFUSION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PANCREAS CANCER; PERIAMPULLARY CANCER; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

ADULT; AGED; AGED, 80 AND OVER; AMPULLA OF VATER; COMMON BILE DUCT NEOPLASMS; FEMALE; HMGA1A PROTEIN; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PANCREATIC NEOPLASMS; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 78649635894     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2010.07.024     Document Type: Article

References (43)

1. A. Jemal, R. Siegel, and E. Ward Cancer statistics, 2009 CA Cancer J Clin 59 2009 225 249
2. S. Boeck, D.P. Ankerst, and V. Heinemann The role of adjuvant chemotherapy for patients with resected pancreatic cancer: systematic review of randomized controlled trials and meta-analysis Oncology 72 2007 314 321
3. N. Merchant, and J. Berlin Past and future of pancreas cancer: are we ready to move forward together? J Clin Oncol 26 2008 3478 3480
4. T. Lund, J. Holtlund, M. Fredriksen, and S.G. Laland On the presence of two new high mobility group-like proteins in HeLa S3 cells FEBS Lett 152 1983 163 167
5. A. Fusco, and M. Fedele Roles of HMGA proteins in cancer Nat Rev Cancer 7 2007 899 910
6. R. Reeves Molecular biology of HMGA proteins: hubs of nuclear function Gene 277 2001 63 81
7. K.R. Johnson, D.A. Lehn, and R. Reeves Alternative processing of mRNAs encoding mammalian chromosomal high-mobility-group proteins HMG-I and HMG-Y Mol Cell Biol 9 1989 2114 2123
8. S. Nagpal, C. Ghosn, and D. DiSepio Retinoid-dependent recruitment of a histone H1 displacement activity by retinoic acid receptor J Biol Chem 274 1999 22563 22568
9. G. Chiappetta, V. Avantaggiato, and R. Visconti High level expression of the HMGI (Y) gene during embryonic development Oncogene 13 1996 2439 2446
10. V. Giancotti, M.T. Berlingieri, and P.P. DiFiore Changes in nuclear proteins on transformation of rat epithelial thyroid cells by a murine sarcoma retrovirus Cancer Res 45 1985 6051 6057
11. V. Giancotti, B. Pani, and P. D'Andrea Elevated levels of a specific class of nuclear phosphoproteins in cells transformed with v-ras and v-mos oncogenes and by cotransfection with c-myc and polyoma middle T genes EMBO J 6 1987 1981 1987
12. Y. Tamimi, H.G. van der Poel, and M.M. Denyn Increased expression of high mobility group protein I(Y) in high grade prostatic cancer determined by in situ hybridization Cancer Res 53 1993 5512 5516
13. Y. Tamimi, H.G. van der Poel, H.F. Karthaus, F.M. Debruyne, and J.A. Schalken A retrospective study of high mobility group protein I(Y) as progression marker for prostate cancer determined by in situ hybridization Br J Cancer 74 1996 573 578
14. G. Chiappetta, A. Bandiera, and M.T. Berlingieri The expression of the high mobility group HMGI (Y) proteins correlates with the malignant phenotype of human thyroid neoplasias Oncogene 10 1995 1307 1314
15. G. Chiappetta, G. Tallini, and M.C. De Biasio Detection of high mobility group I HMGI(Y) protein in the diagnosis of thyroid tumors: HMGI(Y) expression represents a potential diagnostic indicator of carcinoma Cancer Res 58 1998 4193 4198
16. M. Fedele, A. Bandiera, and G. Chiappetta Human colorectal carcinomas express high levels of high mobility group HMGI(Y) proteins Cancer Res 56 1996 1896 1901
17. D.H. Kim, Y.S. Park, and C.J. Park Expression of the HMGI(Y) gene in human colorectal cancer Int J Cancer 84 1999 376 380
18. N. Abe, T. Watanabe, and M. Sugiyama Determination of high mobility group I(Y) expression level in colorectal neoplasias: a potential diagnostic marker Cancer Res 59 1999 1169 1174
19. G. Chiappetta, G. Manfioletti, and F. Pentimalli High mobility group HMGI(Y) protein expression in human colorectal hyperplastic and neoplastic diseases Int J Cancer 91 2001 147 151
20. M. Balcerczak, G. Pasz-Walczak, and E. Balcerczak HMGI(Y) gene expression in colorectal cancer: comparison with some histological typing, grading, and clinical staging Pathol Res Pract 199 2003 641 646 (Pubitemid 37493370)
21. A. Bandiera, D. Bonifacio, and G. Manfioletti Expression of HMGI(Y) proteins in squamous intraepithelial and invasive lesions of the uterine cervix Cancer Res 58 1998 426 431
22. N. Abe, T. Watanabe, and T. Masaki Pancreatic duct cell carcinomas express high levels of high mobility group I(Y) proteins Cancer Res 60 2000 3117 3122
23. N. Abe, T. Watanabe, and Y. Izumisato Diagnostic significance of high mobility group I(Y) protein expression in intraductal papillary mucinous tumors of the pancreas Pancreas 25 2002 198 204
24. S.S. Liau, F. Rocha, E. Matros, M. Redston, and E. Whang High mobility group AT-hook 1 (HMGA1) is an independent prognostic factor and novel therapeutic target in pancreatic adenocarcinoma Cancer 113 2008 302 314
25. E.S. Nam, D.H. Kim, and S.J. Cho Expression of HMGI(Y) associated with malignant phenotype of human gastric tissue Histopathology 42 2003 466 471
26. V. Masciullo, G. Baldassarre, and F. Pentimalli HMGA1 protein over-expression is a frequent feature of epithelial ovarian carcinomas Carcinogenesis 24 2003 1191 1198
27. G. Chiappetta, G. Botti, and M. Monaco HMGA1 protein overexpression in human breast carcinomas: correlation with ErbB2 expression Clin Cancer Res 10 2004 7637 7644
28. Z.G. Chang, L.Y. Yang, and W. Wang Determination of high mobility group A1 (HMGA1) expression in hepatocellular carcinoma: a potential prognostic marker Dig Dis Sci 50 2005 1764 1770
29. V.K. Sarhadi, H. Wikman, and K. Salmenkivi Increased expression of high mobility group A proteins in lung cancer J Pathol 209 2006 206 212
30. A. Tesfaye, F. Di Cello, and J. Hillion The high-mobility group A1 gene up-regulates cyclooxygenase 2 expression in uterine tumorigenesis Cancer Res 67 2007 3998 4004
31. Y.S. Rho, Y.C. Lim, and I.S. Park High mobility group HMGI(Y) protein expression in head and neck squamous cell carcinoma Acta Otolaryngol 127 2007 76 81
32. G.M. Pierantoni, V. Agosti, and M. Fedele High-mobility group A1 proteins are overexpressed in human leukaemias Biochem J 372 2003 145 150
33. A.M. Flohr, P. Rogalla, and U. Bonk High mobility group protein HMGA1 expression in breast cancer reveals a positive correlation with tumour grade Histol Histopathol 18 2003 999 1004
34. R. Franco, F. Esposito, and M. Fedele Detection of high-mobility group proteins A1 and A2 represents a valid diagnostic marker in post-pubertal testicular germ cell tumours J Pathol 214 2008 58 64
35. G. Giannini, C.J. Kim, and L. Di Marcotullio Expression of the HMGI(Y) gene products in human neuroblastic tumours correlates with differentiation status Br J Cancer 83 2000 1503 1509
36. S. Scala, G. Portella, M. Fedele, G. Chiappetta, and A. Fusco Adenovirus-mediated suppression of HMGI(Y) protein synthesis as potential therapy of human malignant neoplasias Proc Natl Acad Sci USA 97 2000 4256 4261
37. F. Trapasso, M. Sarti, and R. Cesari Therapy of human pancreatic carcinoma based on suppression of HMGA1 protein synthesis in preclinical models Cancer Gene Ther 11 2004 633 641
38. S.S. Liau, A. Jazag, and E.E. Whang HMGA1 is a determinant of cellular invasiveness and in vivo metastatic potential in pancreatic adenocarcinoma Cancer Res 66 2006 11613 11622
39. S.S. Liau, A. Jazag, K. Ito, and E.E. Whang Overexpression of HMGA1 promotes anoikis resistance and constitutive Akt activation in pancreatic adenocarcinoma cells Br J Cancer 96 2007 993 1000
40. S.S. Liau, and E. Whang HMGA1 is a molecular determinant of chemoresistance to gemcitabine in pancreatic adenocarcinoma Clin Cancer Res 14 2008 1470 1477
41. M.J. Morak, A. van der Gaast, and L. Incrocci Adjuvant intra-arterial chemotherapy and radiotherapy versus surgery alone in resectable pancreatic and periampullary cancer: a prospective randomized controlled trial Ann Surg 248 2008 1031 1041
42. H.G. Smeenk, C.H. van Eijck, and W.C. Hop Long-term survival and metastatic pattern of pancreatic and periampullary cancer after adjuvant chemoradiation or observation: long-term results of EORTC trial 40891 Ann Surg 246 2007 734 740
43. G. Chiappetta, A. Ottaiano, and E. Vuttariello HMGA1 protein expression in familial breast carcinoma patients Eur J Cancer 46 2010 332 339